Cheryl Guttman Krader, BS, Pharm

Conbercept is an anti-vascular endothelial growth factor (VEGF) drug approved for the treatment of wet age-related macular degeneration in China. Compared with agents used in the United States, it has a higher binding affinity, lower VEGF dissociation rate, and longer clearance time.

The Steroids for Corneal Ulcers Trial allays some fears about using a topical corticosteroid as an adjunct to antibiotic treatment in eyes with a bacterial corneal ulcer.

Since dry eye is an early presenting sign, eye-care providers need to maintain a high index of suspicion for Sjögren’s syndrome in patients with clinically significant dry eye.

Maintenance is an important determinant for the efficacy of any intervention

New diagnostic platforms for dry eye disease can help in determining the underlying cause and severity, which is useful for guiding treatment decisions.

Children are particularly sensitive to systemic side effects of topical glaucoma medications for a variety of reasons. Increased caution is necessary when using these agents.

Achieving alignment of strabismus can be difficult in children with syndromic craniosynostosis as the causes are multifactorial.